|
JP2001523695A
(ja)
*
|
1997-11-24 |
2001-11-27 |
ザ スクリップス リサーチ インスティテュート |
ギャップ結合連絡の阻害剤
|
|
US6858649B1
(en)
*
|
1998-04-30 |
2005-02-22 |
The Scripps Research Institute |
Selective potentiation of serotonin receptor subtypes
|
|
GB9926833D0
(en)
*
|
1999-11-15 |
2000-01-12 |
Univ Sunderland |
Compositions
|
|
CA2437353A1
(en)
*
|
2001-02-08 |
2002-08-15 |
Nps Pharmaceuticals, Inc. |
Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
|
|
AU2002338329B2
(en)
|
2001-03-27 |
2006-09-07 |
The Regents Of The University Of California |
Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
|
|
US20050054730A1
(en)
*
|
2001-03-27 |
2005-03-10 |
The Regents Of The University Of California |
Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha
|
|
WO2003011220A2
(en)
*
|
2001-07-31 |
2003-02-13 |
The Scripps Research Institute |
Animal model for fatty acid amide-related neurobehaviors
|
|
ES2186576B1
(es)
*
|
2001-10-11 |
2004-09-16 |
Universitat De Les Illes Balears |
Acido 2-hidroxioleico para utilizar como medicamento.
|
|
US20040063726A1
(en)
*
|
2002-02-08 |
2004-04-01 |
Artman Linda D |
Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
|
|
EP1558591B1
(en)
*
|
2002-10-07 |
2014-05-07 |
The Regents of The University of California |
Modulation of anxiety through blockade of anandamide hydrolysis
|
|
US7765162B2
(en)
*
|
2002-10-07 |
2010-07-27 |
Mastercard International Incorporated |
Method and system for conducting off-line and on-line pre-authorized payment transactions
|
|
JP2007509066A
(ja)
*
|
2003-10-16 |
2007-04-12 |
ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
体脂肪を減らし、食欲を抑制し、脂肪酸代謝を調節するための食物および他の組成物、化合物ならびに方法
|
|
AR055831A1
(es)
|
2004-12-30 |
2007-09-12 |
Janssen Pharmaceutica Nv |
Pepirazinilureas y piperidinilureas como moduladores de hidrolasa de amida de acidos grasos
|
|
WO2006116773A2
(en)
*
|
2005-04-28 |
2006-11-02 |
The Regents Of The University Of California |
Methods, compositions, and compounds for modulation of monoacylglycerol lipase, pain, and stress-related disorders
|
|
PE20070099A1
(es)
|
2005-06-30 |
2007-02-06 |
Janssen Pharmaceutica Nv |
N-heteroarilpiperazinil ureas como moduladores de la amida hidrolasa del acido graso
|
|
EP1954137A4
(en)
*
|
2005-11-18 |
2008-12-17 |
Janssen Pharmaceutica Nv |
2-KETO-OXAZOLE AS MODULATORS OF FATTY ACID AMIDHYDROLASE
|
|
JP2009527483A
(ja)
|
2006-02-17 |
2009-07-30 |
ザ・スクリプス・リサーチ・インステイチユート |
脂肪酸アミドヒドロラーゼの調節因子としてのオキサゾールケトン
|
|
JP2009538358A
(ja)
*
|
2006-05-26 |
2009-11-05 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
脂肪酸アミド加水分解酵素のオキサゾリルピペリジン・モジュレーター
|
|
WO2008030752A2
(en)
*
|
2006-09-07 |
2008-03-13 |
N.V. Organon |
Methods for determining effective doses of fatty acid amide hydrolase inhibitors in vivo
|
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
|
US20080119549A1
(en)
*
|
2006-11-20 |
2008-05-22 |
N.V. Organon |
Metabolically-stabilized inhibitors of fatty acid amide hydrolase
|
|
TW201000107A
(en)
*
|
2008-04-09 |
2010-01-01 |
Infinity Pharmaceuticals Inc |
Inhibitors of fatty acid amide hydrolase
|
|
ES2342997B1
(es)
|
2008-12-09 |
2011-06-06 |
Universitat De Les Illes Balears |
Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento.
|
|
WO2010118155A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
CA2757622A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
US9062116B2
(en)
|
2009-04-23 |
2015-06-23 |
Infinity Pharmaceuticals, Inc. |
Anti-fatty acid amide hydrolase-2 antibodies and uses thereof
|
|
US8765735B2
(en)
*
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US9149465B2
(en)
*
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US8927551B2
(en)
*
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US20120225097A1
(en)
|
2009-11-12 |
2012-09-06 |
Hawryluk Natalie A |
Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
|
|
MX361692B
(es)
|
2010-02-03 |
2018-12-13 |
Infinity Pharmaceuticals Inc |
Inhibidores de amida hidrolasa de ácido graso.
|
|
UA108233C2
(uk)
|
2010-05-03 |
2015-04-10 |
|
Модулятори активності гідролази амідів жирних кислот
|
|
DK3362462T3
(da)
|
2015-10-12 |
2021-10-11 |
Advanced Cell Diagnostics Inc |
In situ-detektion af nukleotidvarianter i prøver med højt støjniveau, og sammensætninger og fremgangsmåder relateret dertil
|
|
WO2021097069A1
(en)
*
|
2019-11-12 |
2021-05-20 |
The Trustees Of The University Of Pennsylvania |
Oleic acid derivatives as treatments for friedreich ataxia and inhibitors of ferroptosis
|
|
CN111004125B
(zh)
*
|
2019-12-24 |
2022-11-22 |
东华理工大学 |
一种缩醛或缩酮化合物的制备方法
|
|
CN115052852A
(zh)
|
2020-01-29 |
2022-09-13 |
巴利阿里群岛大学 |
α-羟基化脂肪酸代谢产物、其医学用途以及作为生物标志物的用途
|